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Background: Although several determinants of global developmental delay (GDD) have been recognized, a
significant number of children remain without definitive etiologic diagnosis. The objective of this study was to
assess the effect of various prenatal and perinatal factors on the severity and outcome of developmental delay
without definitive etiologic yield.
Methods: From March 2008 to February 2010, 142 children with developmental quotient (DQ) <70 and without
definitive etiologic diagnosis, were included. Prenatal and perinatal risk factors known to be associated with
disordered neonatal brain function were identified. Participants underwent a thorough investigation, an
individualized habilitation plan was recommended, and the children were followed-up regularly for a period of
2 years. The effect of prenatal and perinatal risk factors on the severity and outcome of GDD was assessed by
regression analysis.
Results: The mean age at enrolment was 31 ± 12 months, and the mean DQ 52.2 ± 11.4. Prematurity and
intrauterine growth restriction (IUGR) were found to be independently associated with lower DQ values. The mean
DQ after the 2-year follow-up was 62.5 ± 12.7, and the DQ difference from the enrollment 10.4 ± 8.9 (median 10;
range−10 to 42). DQ improvement (defined as a DQ difference ≥median) was noted in 52.8% of the children. IUGR,
low socio-economic status, and poor compliance to habilitation plan were found to be independently associated
with poorer developmental outcomes.
Conclusions: Prematurity and IUGR were found to be significantly and independently related to the severity of
GDD in cases without definitive etiologic yield. Poorer 2-year developmental outcome was associated with IUGR,
low socioeconomic status and non compliance to habilitation plan. Prematurity was a significant determinant of
the outcome only in association with the above mentioned factors.
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Developmental disabilities of childhood represent a group
of heterogeneous disorders characterized by age-specific
limitations in the acquisition of adaptation and learning
skills [1,2]. The term global developmental delay (GDD) is
used to describe developmental disability in children less
than 5 years of age [3], and refers to a significant delay in
at least two of the major developmental domains: gross
and fine motor; speech and language; cognition; social and
personal development; and activities of daily living [3,4].
Although it is generally estimated that developmental dis-
abilities affect 5-10% of the pediatric population [1], the
reported prevalence varies widely depending on case def-
inition, age range, and population socioeconomic charac-
teristics [5,6]. The precise prevalence of GDD is also
unknown. Estimates of 1-5% have been reported in west-
ernized societies [7,8], but the percentage of young chil-
dren who do not reach their developmental potential is
higher in the developing world [6,9].
Accurate determination of the underlying etiology rep-
resents an essential step in the management of young
children with developmental disabilities [3,4]. However,
the reported etiologic yield of GDD is extremely variable,
ranging from 10 to 80% in different studies [3,10-12].
Determinants of GDD may be broadly classifiable as pre-
natal, perinatal and postnatal, and traditionally include
genetic syndromes or chromosomal anomalies, hypoxic-
ischemic encephalopathy (HIE), cerebral dysgenesis, early
severe psychosocial deprivation, antenatal toxin exposure,
and central nervous system (CNS) infections [3]. Disor-
dered neonatal brain function, also known as neonatal en-
cephalopathy (NE), is a clinical syndrome associated with
life-long chronic disabilities, including cerebral palsy and
various cognitive, developmental and behavioral problems
[13]. In studies undertaken to assess the underlying eti-
ology of GDD [3,10-12,14,15], NE is often used synonym-
ously with HIE, although the latter actually refers to a
sub-set of cases with clear evidence of a perinatal hypoxic-
ischemic event [16,17]. However, disordered neonatal
brain function is associated with a number of risk factors,
including but not limited to perinatal hypoxia-ischemia
[13,16-18]. Many of these factors may be preventable or
modifiable, and thus, their prompt identification may have
significant clinical and prognostic implications [13].
The aim of this study was to assess the effect of vari-
ous prenatal and perinatal factors known to be associ-
ated with NE, on the severity of developmental disability
in a cohort of children with significant GDD without de-
finitive etiologic yield. The influence of these factors on
the clinical course of GDD was also assessed, taking into
account various confounders such as socio-economic
status of the family and compliance to the recommended
habilitation plan. Our study hypothesis was that factors
associated with disordered neonatal brain function mayhave a significant and independent effect on the severity
and course of developmental delay in young children.
Methods
The study was conducted between March 2008 and
February 2012 at the Developmental Assessment Unit
of the “P & A Kyriakou” Childrens Hospital in Athens,
Greece, one of the main referral Developmental Pediatric
centers of the country.
Participants and protocol
During a 2-year inclusive period (March 2008–February
2010), children younger than 5 years of age referred to
our Unit for suspected developmental delay were screened
for eligibility. Participants should have had significant
GDD, (defined as a developmental quotient–DQ <70)
without a definitive etiologic diagnosis including HIE,
pathologic neonatal neuroimaging, chromosomal abnor-
malities, genetic syndromes, metabolic or neuromuscular
disorders, congenital infections, central nervous system
(CNS) malformations, congenital hypothyroidism, CNS
infections or severe injuries beyond the neonatal period,
toxin exposure, or severe psychosocial neglect. If such a
disorder was diagnosed at presentation (or during the
following 2-year follow-up period), the child was not
included in the study (or was, respectively, excluded).
Children with autistic features were also excluded.
Developmental assessment was completed by an expe-
rienced developmental pediatrician using the Bayley
Scales of Infant Development [19] for children up to
3 years of age, and the Griffiths Scales for Mental Devel-
opment [20] and the Athina Test [21] for older children.
The lower DQ value was taken into account when both
Griffiths Scales for Mental Development and the Athina
Test were used. Developmental quotient was calculated
as percentage of functional age compared to chrono-
logical age.
Information regarding the perinatal and the neonatal
period was obtained by a systematic examination of the
participants’ medical records, including personal health
booklets, hospital discharge notes, follow-up or out-
patient information notes, and any related laboratory or
imagistic examination from the personal medical files. A
detailed history was also obtained from the parents and
the referring physician was contacted for any additional
information. The diagnosis of HIE was based on the cri-
teria established by the American Academy of Pediatrics
task Force on Neonatal Encephalopathy and Cerebral
Palsy [17], which include evidence of metabolic acidosis
in fetal umbilical cord arterial blood at delivery, early
onset of severe or moderate neonatal encephalopathy,
and cerebral palsy of the spastic quadriplegic or dyski-
netic type. If the diagnosis of HIE was not definitive,
but there was evidence of a non-specific asphyxial
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ately before or during labor, sudden and sustained fetal
bradycardia or absence of fetal heart rate variability,
Apgar score of less than 5 beyond 5 minutes) [16] with-
out pathologic findings in neonatal neuroimaging, the
child was considered as having experienced birth as-
phyxia without significant CNS involvement and was
not excluded from the study. Pathologic neonatal neu-
roimaging (brain ultrasound, CT, MRI) findings in-
cluded intraventricular hemorrhage, ventriculomegaly
(symmetrical or asymmetrical), periventricular hypere-
chogenicity (localized or diffused), multiple micro or
macro cysts in the periventricular white matter, and
cortical or subcortical infarcts. Children with such find-
ings were excluded from the study irrespectively of the
clinical diagnosis.
Factors known to be associated with NE [13,16-18]
were also recorded. These included in vitro fertilization
(IVF), alcohol, illicit drugs, and tobacco smoke exposure
during pregnancy, multiple gestation, prematurity (defined
as gestational age <37 weeks), post-term birth (defined as
gestational age >42 weeks), intrauterine growth restriction
(IUGR–defined as a ponderal index <10th percentile),
hypertensive disease of pregnancy (preeclampsia, eclamp-
sia), hemorrhagic complications of pregnancy (placental
abruption, placenta previa), mode of delivery, birth asphyxia
(defined by the criteria analyzed above), neonatal hypoxia
(need for ventilatory support due to significant respiratory
deterioration, including respiratory distress syndrome and
apneas), neonatal infection, and severe hyperbilirubinemia.
Failure to thrive was defined as child’s weight for age
below the fifth percentile of the standard Greek growth
charts [22]. The socio-economic status of the family was
also assessed based on parental profession (i.e., manual,
employee, or academic) and years of education, as was de-
scribed elsewhere [23].
Children underwent a thorough investigation according
to the guidelines applied in our Department, including bio-
chemistry, metabolic tests, chromosome analysis, cytogenic
study, electroencephalography (EEG), and neuroimaging
(CT, MRI). A habilitation plan (special education support,
language therapy, behavioral or occupational therapy, and
social support in the community) was recommended on an
individualized case-by-case basis. Participants were asked
to attend our Department regularly at 6-months intervals.
Only follow-up data obtained during the first 2 years after
the initial presentation were used in the present study. At
each follow-up visit, progress (in terms of DQ improve-
ment) was assessed and investigations and treatment plans
were reviewed.
The present study was strictly adhered to the protocols
for the management of GDD applied in our institution.
Physical examination, specific laboratory testing, and
treatment options and recommendations were carriedout only at the discretion of the attending specialist on an
individualized case-by-case basis. The study was approved
by the Ethics Committee of the “P & A Kyriakou” Childrens
Hospital. An informed consent was obtained from one of
the parent of each child at the enrollment.
Statistical analysis
All data were recorded on a standardized data sheet.
Descriptive statistics were generated and exploratory
analysis on the relation between DQ at the enrollment
and the presence of risk factors was performed. Linear
regression analysis was used to assess both crude (un-
adjusted) and combined (adjusted) effects of these fac-
tors on the initial GDD severity. The DQ difference
between the 2-year visit and the initial assessment was
calculated and DQ improvement was defined as a DQ
difference equal or greater than the median DQ difference
of the study cohort. Logistic regression analysis was used
to assess the crude and combined effects of risk factors on
DQ improvement (GDD course) taking also into account
confounders such as lower socioeconomic status and non
adherence to habilitation plan. These effects were pre-
sented as risk ratios (RR). A significance level of 0.05 was
selected for all hypotheses. Statistical analysis was per-
formed using SPSS v.17 (SPSS Inc., Chicago, IL).
Results
During the inclusive period, a total of 296 children
younger than 5 years of age were referred for suspected
developmental delay to our Developmental Pediatric De-
partment and were consecutively screened for enrolment
in the study. Of these, 21 did not meet the criteria for
significant GDD upon specialty evaluation, 7 were diag-
nosed with autism, 79 children were excluded due to a
definitive etiologic diagnosis (HIE 28, pathologic neo-
natal neuroimaging 21, chromosomal abnormalities 11,
genetic syndromes 9. metabolic diseases 3, neuromuscu-
lar disorders 3, CNS infections beyond the neonatal
period 2, and CNS injury 2), 6 children suffered severe
psychosocial deprivation, 29 were excluded due to in-
complete personal medical records, and 12 were lost to
follow-up. The remaining 142 children constituted our
main study cohort.
Ninety of the participants (63.4%) were males. The mean
age at the enrolment was 31 ± 12 months. Sixty children
(42.2%) were from families of low socio-economic status.
Failure to thrive was documented in 23 children (16.2%).
The mean DQ at the enrollment was 52.2 ± 11.4. The DQ
of children initially assessed by the Bayley Scales of Infant
Development (N = 88) was 51.7 ± 10.9, whereas of those
assessed by Griffiths Scales for Mental Development and
Athina Test 53 ± 13.5 (P = 0.530). Lower socio-economic
status and failure to thrive were both associated with sig-
nificantly lower DQ values (44.3 ± 12.1 vs. 58.1 ± 11.7;
Table 2 Effect of various prenatal and perinatal risk






Fecundation in vitro −0.145 −0.101
Drug exposure in pregnancy§ −0.021 −0.019
Tobacco smoke exposure in pregnancy −0.147 −0.113
Multiple gestation −0.193* −0.098
Prematurity −0.276* −0.177†
Post-term birth −0.059 −0.032
Thomaidis et al. BMC Pediatrics 2014, 14:40 Page 4 of 7
http://www.biomedcentral.com/1471-2431/14/40P <0.001 and 43.9 ± 11.8 vs. 53.8 ± 11.1; P <0.001
respectively).
On exploratory analysis, factors associated with lower
DQ were prematurity, multiple gestation, IUGR, hyper-
tensive disease of pregnancy, birth asphyxia, and neo-
natal hypoxia (Table 1). Unadjusted linear regression
analysis confirmed the above findings (Table 2). When
the combined effect of these factors was assessed, only
prematurity and IUGR were found to be independently
associated with significantly lower DQ (Table 2).
During the 2-year follow-up period, all children
underwent a thorough developmental investigation,Table 1 Initial developmental quotient in relation to
various prenatal and perinatal risk factors
N DQ P
Prenatal factors
Fecundation in vitro yes 7 46 ± 12.1 0.124
no 135 52.5 ± 10.8
Drug exposure in pregnancy* yes 14 51.2 ± 11.3 0.734
no 128 52.3 ± 11.5
Tobacco smoke exposure in pregnancy yes 42 50.0 ± 11.4 0.127
no 100 53.1 ± 10.8
Multiple gestation yes 12 44.1 ± 11.2 0.012
no 130 52.9 ± 11.4
Prematurity yes 43 46.8 ± 11.6 <0.001
no 99 54.5 ± 11.0
Post-term birth yes 11 50.1 ± 12.3 0.517
no 131 52.4 ± 11.2
IUGR yes 32 42.8 ± 11.1 <0.001
no 110 54.9 ± 11.4
Hypertensive disease of pregnancy † yes 9 44.2 ± 10.9 0.030
no 133 52.7 ± 11.3
Hemorrhagic complications of
pregnancy ‡
yes 13 48.3 ± 11.6 0.180
no 129 52.6 ± 10.9
Perinatal factors
Cesarean section yes 55 51.3 ± 11.3 0.445
no 87 52.8 ± 11.4
Birth asphyxia yes 18 45.8 ± 12.0 0.012
no 124 53.1 ± 11.3
Neonatal hypoxia § yes 40 48.4 ± 11.5 0.014
no 102 53.7 ± 11.4
Neonatal infection yes 9 46.3 ± 12.2 0.109
no 133 52.6 ± 11.3
Data are means ± SD.
*exposure to alcohol and illicit drugs; † preeclampsia, eclampsia; ‡ placental
abruption, placenta previa; § need for ventilatory support due to respiratory
distress or severe apneas;
DQ indicates developmental quotient; IUGR intrauterine growth restriction.
IUGR −0.301* −0.256*
Hypertensive disease of pregnancy || −0.160‡ −0.128
Hemorrhagic complications of pregnancy ¶ −0.150 −0.106
Perinatal factors
Cesarean section −0.082 −0.049
Birth asphyxia −0.190* −0.125
Neonatal hypoxia** −0.181† −0.090
Neonatal infection −0.150 −0.089
Data are standardized coefficients beta resulted by linear regression analysis.
Unadjusted effect is the effect of each factor separately. Adjusted effect is
the effect of each factor adjusted for the effect of the others and for socio-
economic status (multiple regression model).
*P <0.001; † P <0.01; ‡ P <0.05.
§ exposure to alcohol and illicit drugs; || preeclampsia, eclampsia; ¶ placental
abruption, placenta previa; **need for ventilatory support due to respiratory
distress or severe apneas;
IUGR indicates intrauterine growth restriction.including biochemistry and endocrinological investigations
(N = 142), metabolic tests (N = 59), chromosome analysis
(N = 138), cytogenic studies (N = 46), EEG (N = 77) and
neuroimaging (N = 142). The recommended habilitation
plan included (on individual basis) special education sup-
port (N = 131), language therapy (N = 97), behavioral ther-
apy (N = 20), occupational therapy (N = 89), and social
support in the community (N = 98). Compliance to the
above recommendations was noted in 92 cases (64.8%).
One hundred children (70.5%) had 4 follow-up visits, 34
(23.9%) 3 visits, and 8 (5.6%) 2 visits. All children presented
to the follow-up visit at 2 years after the enrolment.
The mean DQ at the 2-year visit was 62.5 ± 12.7,
and the DQ difference between 2-years and enrolment
10.4 ± 8.9 (median 10; range−10 to 42). The DQ differ-
ence in children initially assessed by the Bayley Scales
of Infant Development and later by Griffiths Scales for
Mental Development and Athina Test (N = 88) was 9.7 ±
10.8, whereas that of children assessed by Griffiths Scales
for Mental Development and Athina Test in both instances
(N = 54) 11.5 ± 10.1 (P = 0.325). DQ improvement was de-
fined as a DQ difference ≥10 (population median), and was
noted in 75 children (52.8%); 4 participants showed further
DQ deterioration. Prematurity, IUGR, neonatal hypoxia,
low socio-economic status, and compliance to treatment
Table 4 Effect of various factors on the course of
developmental delay
Factors Risk ratio for poor DQ
progress † (95% CI)
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IUGR, low socio-economic status, and compliance to ha-
bilitation plan were found to be independently associated
with poorer GDD outcomes (Table 4).Table 3 Course of developmental delay over the 2-year
surveillance period in relation to various factors
Factors DQ difference* P
Median Range
Prenatal
Fecundation in vitro yes 9.2 −4.0 to 23.0 0.687
no 10.0 −10 to 42.0
Drug exposure in pregnancy † yes 8.5 −10 to 27.0 0.244
no 10.0 −5.0 to 42.0
Tobacco smoke exposure in
pregnancy
yes 9 −10.0 to 35.0 0.340
no 10.0 −5.0 to 42.0
Multiple gestation yes 9.0 −10.0 to 20.0 0.169
no 10.0 −5.0 to 42.0
Prematurity yes 7.5 −10.0 to 18.0 0.022
no 10.0 −4.0 to 42.0
IUGR yes 7.0 −10.0 to 15.0 0.006
no 10.0 0.0 to 42.0
Hypertensive disease of
pregnancy ‡
yes 9.5 −10.0 to 38.0 0.904
no 10.0 −5.0 to 42.0
Hemorrhagic complications of
pregnancy §
yes 9.0 −10.0 to 36.0 0.820
no 10.00 −5.0 to 42.0
Perinatal
Cesarean section yes 10.0 −10.0 to 36.0 0.880
no 10.0 −5.0 to 42.0
Birth asphyxia yes 9.0 −5.0 to 35.0 0.620
no 10.0 −10.0 to 42.0
Neonatal hypoxia || yes 8.0 −10.0 to 15.0 0.024
no 10.5 0.0 to 42.0
Neonatal infection yes 9.0 −4.0 to 42.0 0.870
no 10.0 −10.0 to 35.0
Other
Low socio-economic status yes 6.0 −10.0 to 10.0 <0.001
no 11.0 0.0 to 42.0
Adherence to recommendations
and treatment
yes 12.0 0.0 to 42 <0.001
no 5.0 −10.0 to 12
*calculated as DQ(2-year visit)–DQ(initial visit).
Between-group differences are calculated with Mann–Whitney U test.
†exposure to alcohol and illicit drugs; ‡ preeclampsia, eclampsia; § placental
abruption, placenta previa; || need for ventilatory support due to respiratory
distress or severe apneas.
DQ indicates developmental quotient; IUGR intrauterine growth restriction.
Unadjusted Adjusted
Prenatal
Fecundation in vitro 1.3 (0.3–7.9) 1.1 (0.3–6.5)
Drug exposure in pregnancy ‡ 1.3 (0.5–6.6) 1.4 (0.6–7.4)
Tobacco smoke exposure in pregnancy 1.1 (0.7–2.2) 1.2 (0.7–3.0)
Multiple gestation 1.5 (0.8–6.9) 1.6 (0.8–7.4)
Prematurity 3.0 (1.3–7.8)* 2.1 (0.8–7.2)
IUGR 4.3 (1.5–9.0)* 5.1 (1.8–11.0)*
Hypertensive disease of pregnancy § 1.1 (0.3–7.8) 1.0 (0.3–6.9)
Hemorrhagic complications of
pregnancy ||
1.2 (0.4–7.1) 1.0 (0.4–6.5)
Perinatal
Cesarean section 1.0 (0.5–2.8) 1.0 (0.5–3.2)
Birth asphyxia 1.5 (0.7–7.7) 1.6 (0.8–8.1)
Neonatal hypoxia ¶ 2.3 (1.2–7.7)* 2.0 (0.8–7.0)
Neonatal infection 1.2 (0.4–9.0) 1.2 (0.5–8.5)
Other
Low socio-economic status** 4.8 (2.4–9.9)* 4.6 (2.0–7.8)*
No adherence to treatment †† 5.5 (2.9–10.4)* 8.5 (3.4–15.5)*
Data are relative risk ratios calculated by logistic regression analysis.
Unadjusted effect is the effect of each factor separately. Adjusted effect is the
effect of each factor adjusted for the effect of the others (multiple regression
model). Significant effect is indicated by (*).
† Poor DQ progress defined as DQ(2-year visit)–DQ(initial visit) less than
population median.
‡ exposure to alcohol and illicit drugs; § preeclampsia, eclampsia; || placental
abruption, placenta previa; ¶ need for ventilatory support due to respiratory
distress or severe apneas.
**N = 60; †† N = 50.
DQ indicates developmental quotient; IUGR intrauterine growth restriction.Discussion
Developmental disabilities represent a common problem
in pediatric care and a common reason for referral to de-
velopmental or neurology subspecialists [7,8]. However,
their heterogeneous nature, together with the wide-ranging
underlying etiology and the considerable uncertainty
with respect to the extent of investigations to be under-
taken, poses a particular challenge for the individual
practitioner [3]. Thus, although several prenatal, perinatal
and postnatal determinants of early developmental disabil-
ity have been recognized, a significant number of children
with GDD remain without a definitive etiologic diagnosis
[3,10-12]. Neonatal encephalopathy represents one of the
main conditions which result in serious limitations in the
acquisition of adaptation and learning skills. Given its esti-
mated incidence of 2.0 to 6.0 per 1000 live births [13], this
syndrome is apparently responsible for a significant pro-
portion of GDD. Neonatal encephalopathy is associated
with a number of adverse prenatal or perinatal events
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is the independent contribution of these factors on the se-
verity and clinical course of developmental delay. To the
best of our knowledge, the present study is the first to as-
sess this effect in a cohort of children with significant
GDD without definitive etiologic yield.
Factors known to be associated with disordered neo-
natal brain function, such as prematurity, multiple gesta-
tion, IUGR, hypertensive disease of pregnancy, birth
asphyxia, and neonatal hypoxia, were all associated with
lower DQ in our study. However, only prematurity and
IUGR were independently associated with more severe
developmental delay, suggesting that these were the
most important predictors of the severity of GDD in our
cohort. On the other hand, prematurity, IUGR, and neo-
natal hypoxia, were also related to a poorer 2-year devel-
opmental outcome. However, when their combined effect
was assessed taking also into account the significant effect
of lower socioeconomic status and non adherence to
treatment, only IUGR was found to be an independent
predictor of the GDD clinical course.
Accumulate evidence suggests that prematurity is not
only associated with interruption of brain development
at early and critical neurodevelopmental stages, but it
also perturbs the trajectory of normal cerebral develop-
ment after birth [24]. Therefore, children born preterm,
and especially those who survive severe or extreme pre-
maturity, will face a number of neurobehavioral, adaptive
and social challenges. Interestingly, these neuromotor,
cognitive and behavioral impairments seems to be
present across the whole preterm spectrum, from extreme
prematurity to late-preterm birth [24,25]. Although in the
present study prematurity was an important and inde-
pendent predictor of the severity of GDD, its negative ef-
fects on the acquisition of developmental skills seems to
be modifiable. Indeed, prematurity was not an independ-
ent predictor of poorer GDD outcome in our cohort, as
long as it was not associated with low socio-economic sta-
tus and poor compliance to habilitation plan. Although
our findings need further elucidation (prospective studies,
larger sample sizes, different populations and settings),
they underscore the importance of early developmentally
supportive intervention to ensure more optimal neurocog-
nitive outcomes among children born preterm [26].
On the other hand, the developing brain may be more
vulnerable than previously thought to chronic intrauter-
ine substrate deprivation [27]. Recent evidence from pri-
mate animal models suggest that even moderate maternal
undernutrition may lead to major disturbances in the
architecture and maturation of the developing cortical
neuronal network with a potential impact on brain func-
tion over the lifespan [28]. Moreover, data supporting a re-
lation between maternal undernutrition during pregnancy
and cognitive impairment in children have been alsoreported [29]. In agreement with this report, IUGR was
proven to be a major determinant of severity and poor out-
come of GDD in our study. This effect was independent of
other negative perinatal and socio-environmental risk fac-
tors, thus providing further support to a possible link be-
tween IUGR and developmental disabilities in children.
Abnormalities in neuroimaging during the neonatal
period have been considered as a major predictor of cog-
nitive disability in childhood [24,30,31], and it has been
shown that even mild or subclinical findings may be as-
sociated with neurocognitive impairment in later life
[30,32]. Since in our study children with abnormal neo-
natal neuroimaging were excluded, conclusions on this
association cannot be drawn. However, our results
clearly suggest that in the face of a young child with de-
velopmental disability without etiologic yield, the pres-
ence of specific perinatal risk actors should be carefully
assessed irrespectively of the reassuring results of neo-
natal neuroimaging.
Our study has some limitations. First, although partici-
pants were included prospectively and were followed-up
for a period of 2 years, data on prenatal and perinatal
risk factors were collected retrospectively from a detailed
history and the personal medical records. Children with
incomplete medical records were excluded from the
study in order to minimize any related bias, but incom-
plete data assessment still remains a possibility. Second,
the severity and the 2-year outcome of GDD were de-
fined based exclusively on DQ values. Although all DQ
determinations were made by the same experienced de-
velopmental pediatrician, a possible bias due to intraob-
server variability cannot be excluded. To minimize the
effects of such a bias, we chose to include only children
with significant developmental disability (i.e., those with
DQ <70) and to define DQ improvement based on the
median 2-year DQ difference which represented an in-
trinsic characteristic of our study cohort. Third, specific
laboratory testing was carried out on an individualized
case-by-case basis at the discretion of the attending spe-
cialist, therefore, a complete diagnostic panel was not or-
dered in all participants. However, the present study was
not designed to assess the underlying etiology of GDD in
our cohort. Finally, since the sample population comes
from a single referral center in Greece, our results may not
be generalized to other populations and settings where
socioenvironmental factors, referral patterns, subspecialty
assessment protocols, and accessibility to medical care and
developmental supportive interventions may be different.
Conclusion
In conclusion, the results of the present study indicate
that specific prenatal and perinatal factors related to disor-
dered neonatal brain function, such as prematurity and
IUGR, may be significant and independent predictors of
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yield. In contrast to IUGR, however, prematurity was not
a significant determinant of poorer developmental out-
come, provided that it was not associated with low socio-
economic status or poor compliance to habilitation plan.
Our findings suggest that these risk factors may be pre-
ventable or modifiable, and thus, their prompt identifica-
tion combined with an early supportive intervention
strategy may have significant implications on the long-
term outcome of developmental disability.
Abbreviations
GDD: Global developmental delay; HIE: Hypoxic-ischemic encephalopathy;
CNS: Central nervous system; NE: Neonatal encephalopathy;
DQ: Developmental quotient; IVF: In vitro fertilization; IUGR: intrauterine
growth restriction.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
LT: Dr. T conceptualized and designed the study, drafted the initial manuscript,
and approved the final manuscript as submitted. SF: Dr. F carried out the
analyses, drafted the initial manuscript, and approved the final version as
submitted. GZZ and LM: Dr. Z and Dr. M coordinated and supervised data
collection, critically reviewed the manuscript, and approved the final
manuscript as submitted. CB and AK: Prof. B and Prof. K conceptualized
and designed the study, critically reviewed the manuscript, and approved
the final version as submitted.
Financial disclosure
The authors have no financial relationships relevant to this article to disclose.
Received: 14 February 2013 Accepted: 5 February 2014
Published: 12 February 2014
References
1. Simeonson RJ, Sharp MC: Developmental delays. In Primary Pediatric Care.
2nd edition. Edited by Hoekelman RA, Friedman SB, Nelson NM, Seidel HM.
St. Louis: CV Mosby; 1992:867–870.
2. Shevell MI: Present conceptualization of early childhood
neurodevelopmental disabilities. J Child Neurol 2010, 25:120–126.
3. Shevell MI: Global developmental delay and mental retardation/
intellectual disability: conceptualization, evaluation and etiology. In
Developmental Disabilities, Pediatr Clin North Am, Volume 55. Edited by
Greydanus DE, Patel DR, Pratt HD. 2008:1071–1089.
4. Shevell M, Ashwal S, Donley D, et al: Quality standards subcommittee of
the American academy of neurology; practice committee of the child
neurology society: practice parameter: evaluation of the child with
global developmental delay: report of the quality standards
subcommittee of the American Academy of neurology and the practice
committee of the child neurology society. Neurology 2003, 60:367–380.
5. Gottlieb CA, Maenner MJ, Cappa C, Durkin MS: Child disability screening,
nutrition, and early learning in 18 countries with low and middle
incomes: data from the third round of UNICEF’s multiple indicator
cluster survey (2005–06). Lancet 2009, 374:1831–1839.
6. Durkin M: The epidemiology of developmental disabilities in low-income
countries. Ment Retard Dev Disabil Res Rev 2002, 8:206–211.
7. Simpson GA, Colpe L, Greenspan S: Measuring functional developmental
delay in infants and young children: prevalence rates from the NHIS-D.
Paediatr Perinat Epidemiol 2003, 17:68–80.
8. Larson SA, Lakin KC, Anderson L, Kwak N, Lee JH, Anderson D: Prevalence
of mental retardation and developmental disabilities: estimates from the
1994/1995 National health interview survey disability supplements. Am J
Ment Retard 2001, 106:231–252.
9. Engle PL, Black MM, Behrman JR, International Child Development Steering
Group, et al: Strategies to avoid the loss of developmental potential inmore than 200 million children in the developing world. Lancet 2007,
369:229–242.
10. Shevell MI, Majnemer A, Rosenbaum P, Abrahamowicz M: Etiologic yield of
subspecialists’ evaluation of young children with global developmental
delay. J Pediatr 2000, 136:593–598.
11. Shevell MI, Majnemer A, Rosenbaum P, Abrahamowicz M: Etiologic
determination of childhood developmental delay. Brain Dev 2001, 23:228–235.
12. Srour M, Mazer B, Shevell MI: Analysis of clinical features predicting
etiologic yield in the assessment of global developmental delay.
Pediatrics 2006, 118:139–145.
13. Kurinczuk JJ, White-Koning M, Badawi N: Epidemiology of neonatal
encephalopathy and hypoxic-ischaemic encephalopathy. Early Hum Dev
2010, 86:329–338.
14. Ozmen M, Tatli B, Aydinli N, Caliskan M, Demirkol M, Kayserili H: Etiologic
evaluation in 247 children with global developmental delay at Istanbul,
Turkey. J Trop Pediatr 2005, 51:310–313.
15. Sachdeva S, Amir A, Alam S, Khan Z, Khalique N, Ansari MA: Global
developmental delay and its determinants among infants and toddlers:
a cross sectional study. Indian J Pediatr 2010, 77:975–980.
16. Hankins GD, Speer M: Defining the pathogenesis and pathophysiology
of neonatal encephalopathy and cerebral palsy. Obstet Gynecol 2003,
102:628–636.
17. American College of Obstetricians and Gynecologists’ Task Force on Neonatal
Encephalopathy and Cerebral Palsy, American College of Obstetricians and
Gynecologists, American Academy of Pediatrics: Neonatal Encephalopathy and
Cerebral Palsy: Defining the pathogenesis and pathophysiology. Washington:
American College of Obstetricians and Gynecologists; 2003.
18. Badawi N, Kurinczuk JJ, Keogh JM, et al: Intrapartum risk factors for
newborn encephalopathy: the Western Australian case–control study.
BMJ 1998, 317:1554–1558.
19. Bayley N: Bayley Scales of Infant Development. 2nd edition. San Antonio, TX:
Psychological Corp; 1993.
20. Griffiths R: The abilities of young children. High Wycombe, UK: The Test
Agency Ltd; 1984.
21. Paraskevopoulos I, Kalantzi-Azizi A, Yiannitsas N: Athina–test for the diagnosis
of learning difficulties. Athens, GR: Ellinika Grammata; 1999.
22. Raynor P, Rudolf MC: Anthropometric indices of failure to thrive. Arch Dis
Child 2000, 82:364–365.
23. Thomaidis L, Bertou G, Critselis E, Spoulou V, Kafetzis DA, Theodoridou M:
Cognitive and psychosocial development of HIV pediatric patients
receiving highly active anti-retroviral therapy: a case–control study.
BMC Pediatr 2010, 10:99.
24. Baron IS, Rey-Casserly C: Extremely preterm birth outcome: a review of
four decades of cognitive research. Neuropsychol Rev 2010, 20:430–452.
25. Baron IS, Erickson K, Ahronovich MD, Baker R, Litman FR: Cognitive deficit
in preschoolers born late-preterm. Early Hum Dev 2011, 87:115–119.
26. Spittle AJ, Orton J, Doyle LW, Boyd R: Early developmental intervention
programs post hospital discharge to prevent motor and cognitive
impairment in preterm infants. Cochrane Database Syst Rev 2007, 2:CD005495.
27. Giussani DA: The vulnerable developing brain. Proc Natl Acad Sci USA
2011, 108:2641–2642.
28. Antonow-Schlorke I, Schwab M, Cox LA, et al: Vulnerability of the fetal
primate brain to moderate reduction in maternal global nutrient
availability. Proc Natl Acad Sci U S A 2011, 108:3011–3016.
29. Krishnaveni GV, Veena SR, Winder NR, et al: Maternal vitamin D status during
pregnancy and body composition and cardiovascular risk markers in Indian
children: the Mysore parthenon study. Am J Clin Nutr 2011, 93:628–635.
30. Laptook AR, O’Shea TM, Shankaran S, Bhaskar B, NICHD Neonatal Network:
Adverse neurodevelopmental outcomes among extremely low birth
weight infants with a normal head ultrasound: prevalence and
antecedents. Pediatrics 2005, 115:673–680.
31. Inder TE, Wells SJ, Mogridge NB, Spencer C, Volpe JJ: Defining the nature
of the cerebral abnormalities in the premature infant: a qualitative
magnetic resonance imaging study. J Pediatr 2003, 143:171–179.
32. Huang BY, Castillo M: Hypoxic-ischemic brain injury: imaging findings
from birth to adulthood. Radiographics 2008, 28:417–439.
doi:10.1186/1471-2431-14-40
Cite this article as: Thomaidis et al.: Predictors of severity and outcome
of global developmental delay without definitive etiologic yield: a
prospective observational study. BMC Pediatrics 2014 14:40.
